HLA-A3 supermotif defined by quantitative structure-activity relationship analysis.
暂无分享,去创建一个
[1] D. R. Madden,et al. Identification of self peptides bound to purified HLA-B27 , 1991, Nature.
[2] G. Yoo,et al. Foreign antigenic peptides delivered to the tumor as targets of cytotoxic T cells. , 2001, Journal of immunological methods.
[3] M. Mannie. T cell-mediated antigen presentation , 2001, Immunologic research.
[4] Don C. Wiley,et al. Atomic structure of a human MHC molecule presenting an influenza virus peptide , 1992, Nature.
[5] J. Kim,et al. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers , 2001, Experimental & Molecular Medicine.
[6] A Sette,et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.
[7] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.
[8] Irini A. Doytchinova,et al. JenPep: a database of quantitative functional peptide data for immunology , 2002, Bioinform..
[9] O. Rötzschke,et al. Consensus motifs and peptide ligands of MHC class I molecules. , 1993, Seminars in immunology.
[10] G. Nepom,et al. MHC-peptide ligand interactions establish a functional threshold for antigen-specific T cell recognition. , 1999, Human immunology.
[11] J. Sidney,et al. Class I MHC-peptide interaction: structural and functional aspects. , 1994, Behring Institute Mitteilungen.
[12] D. Wiley,et al. Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[13] C DeLisi,et al. Computational determination of side chain specificity for pockets in class I MHC molecules. , 1996, Molecular immunology.
[14] D. Wiley,et al. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. , 1994, Science.
[15] P. A. Peterson,et al. Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.
[16] H Kubinyi,et al. Quantitative structure-activity relationships. 1. The modified Free-Wilson approach. , 1976, Journal of medicinal chemistry.
[17] J. Gutiérrez-Ramos,et al. The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function , 2001, Nature Immunology.
[18] A. Sette,et al. Identification of GP100‐derived, melanoma‐specific cytotoxic T‐lymphocyte epitopes restricted by HLA‐A3 supertype molecules by primary in vitro immunization with peptide‐pulsed dendritic cells , 1998, International journal of cancer.
[19] V. Gnau,et al. Peptide motifs of HLA-A1,-A11,-A31, and-A33 molecules , 1994, Immunogenetics.
[20] Takashi Saito,et al. Dependence of T Cell Antigen Recognition on the Dimensions of an Accessory Receptor–Ligand Complex , 1999, The Journal of experimental medicine.
[21] Hans-Georg Rammensee,et al. MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.
[22] Bruce L. Bush,et al. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA , 1993, J. Comput. Aided Mol. Des..
[23] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[24] J. Sidney,et al. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.
[25] M F del Guercio,et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.
[26] Limsoon Wong,et al. FIMM, a database of functional molecular immunology , 2000, Nucleic Acids Res..
[27] John Sidney,et al. Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding Motif , 2001, Journal of Virology.
[28] S. H. van der Burg,et al. An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301. , 1995, Human immunology.
[29] D. Flower,et al. Additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. , 2002, Journal of proteome research.
[30] G. Klein,et al. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Muñoz de la Peña,et al. Comparative study of partial least squares and a modification of hybrid linear analysis calibration in the simultaneous spectrophotometric determination of rifampicin, pyrazinamide and isoniazid , 2001 .
[32] D. R. Madden,et al. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.
[33] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[34] M. A. Saper,et al. Specificity pockets for the side chains of peptide antigens in HLA-Aw68 , 1990, Nature.
[35] D. Madden. The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.
[36] Han van de Waterbeemd,et al. Chemometric methods in molecular design , 1995 .
[37] Darren R. Flower,et al. Drug design : cutting edge approaches , 2002 .
[38] P Parham,et al. Structure, function, and diversity of class I major histocompatibility complex molecules. , 1990, Annual review of biochemistry.
[39] K. Parker,et al. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.